Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1865 1
1868 2
1876 1
1877 1
1895 1
1913 1
1930 1
1931 5
1933 1
1937 2
1941 1
1945 4
1946 8
1947 7
1948 11
1949 9
1950 7
1951 9
1952 8
1953 7
1954 6
1955 13
1956 6
1957 13
1958 9
1959 15
1960 7
1961 6
1962 27
1963 9
1964 12
1965 12
1966 34
1967 28
1968 15
1969 32
1970 20
1971 16
1972 31
1973 33
1974 35
1975 28
1976 34
1977 42
1978 37
1979 48
1980 35
1981 39
1982 56
1983 58
1984 57
1985 48
1986 53
1987 67
1988 54
1989 53
1990 53
1991 56
1992 56
1993 68
1994 68
1995 75
1996 64
1997 67
1998 86
1999 89
2000 84
2001 63
2002 72
2003 89
2004 74
2005 90
2006 82
2007 86
2008 77
2009 82
2010 104
2011 117
2012 151
2013 182
2014 192
2015 175
2016 188
2017 174
2018 153
2019 141
2020 138
2021 162
2022 153
2023 164
2024 59

Text availability

Article attribute

Article type

Publication date

Search Results

4,511 results

Results by year

Filters applied: . Clear all
Page 1
A Review of the Important Role of CYP2D6 in Pharmacogenomics.
Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM. Taylor C, et al. Among authors: turner rm. Genes (Basel). 2020 Oct 30;11(11):1295. doi: 10.3390/genes11111295. Genes (Basel). 2020. PMID: 33143137 Free PMC article. Review.
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. Swen JJ, et al. Among authors: turner rm. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. Lancet. 2023. PMID: 36739136 Clinical Trial.
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.
Cooper-DeHoff RM, Niemi M, Ramsey LB, Luzum JA, Tarkiainen EK, Straka RJ, Gong L, Tuteja S, Wilke RA, Wadelius M, Larson EA, Roden DM, Klein TE, Yee SW, Krauss RM, Turner RM, Palaniappan L, Gaedigk A, Giacomini KM, Caudle KE, Voora D. Cooper-DeHoff RM, et al. Among authors: turner rm. Clin Pharmacol Ther. 2022 May;111(5):1007-1021. doi: 10.1002/cpt.2557. Epub 2022 Mar 11. Clin Pharmacol Ther. 2022. PMID: 35152405 Free PMC article.
The structural and social determinants of Alzheimer's disease related dementias.
Adkins-Jackson PB, George KM, Besser LM, Hyun J, Lamar M, Hill-Jarrett TG, Bubu OM, Flatt JD, Heyn PC, Cicero EC, Zarina Kraal A, Pushpalata Zanwar P, Peterson R, Kim B, Turner RW 2nd, Viswanathan J, Kulick ER, Zuelsdorff M, Stites SD, Arce Rentería M, Tsoy E, Seblova D, Ng TKS, Manly JJ, Babulal G. Adkins-Jackson PB, et al. Among authors: turner rw 2nd. Alzheimers Dement. 2023 Jul;19(7):3171-3185. doi: 10.1002/alz.13027. Epub 2023 Apr 19. Alzheimers Dement. 2023. PMID: 37074203 Review.
The Metameric Echinoderm.
Turner RL. Turner RL. Integr Org Biol. 2024 Mar 1;6(1):obae005. doi: 10.1093/iob/obae005. eCollection 2024. Integr Org Biol. 2024. PMID: 38558855 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. Among authors: turner rs. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Metal-Resistance in Bacteria: Why Care?
Turner RJ, Huang LN, Viti C, Mengoni A. Turner RJ, et al. Genes (Basel). 2020 Dec 8;11(12):1470. doi: 10.3390/genes11121470. Genes (Basel). 2020. PMID: 33302493 Free PMC article.
Editorial: Metal Resistance in Microorganisms.
Van Houdt R, Hobman JL, Matroule JY, Turner RJ. Van Houdt R, et al. Among authors: turner rj. Front Microbiol. 2022 Apr 11;13:899448. doi: 10.3389/fmicb.2022.899448. eCollection 2022. Front Microbiol. 2022. PMID: 35479625 Free PMC article. No abstract available.
Child-centred harm reduction.
Barrett D, Stoicescu C, Thumath M, Maynard E, Turner R, Shirley-Beavan S, Kurcevič E, Petersson F, Hasselgård-Rowe J, Giacomello C, Wåhlin E, Lines R. Barrett D, et al. Among authors: turner r. Int J Drug Policy. 2022 Nov;109:103857. doi: 10.1016/j.drugpo.2022.103857. Epub 2022 Sep 26. Int J Drug Policy. 2022. PMID: 36174409 Free article.
4,511 results